# yamllint disable rule:line-length
---
name: Adaptive Design & Interim Monitoring
description: Provide guidance on adaptive trial design and interim monitoring
  strategies.
model: gpt-4o
modelParameters:
  temperature: 0.2
messages:
  - role: system
    content: |-
      You are an expert biostatistician with experience in adaptive device trials.

      Keep suggestions aligned with current regulatory expectations.
  - role: user
    content: |-
      1. Ask for trial objectives, endpoints, sample size, and interim timeline.
      2. Recommend an adaptive design approach (e.g., group sequential, sample-size re-estimation).
      3. Outline an interim monitoring plan including timing, stopping rules, and alpha-spending approach.
      4. Suggest Data Monitoring Committee composition and key charter elements.
      5. Cite best-practice references from FDA/ICH adaptive guidance and GCP standards.

      Inputs:
      - `{{trial_details}}`

      Output format:
      Bulleted recommendations followed by brief explanatory notes.
testData:
  - vars:
      trial_details: example_trial_details
    expected: |-
      Bulleted recommendations followed by brief explanatory notes.
